Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Tissue Regenix Group PLC banner

Tissue Regenix Group PLC
LSE:TRX

Watchlist Manager
Tissue Regenix Group PLC Logo
Tissue Regenix Group PLC
LSE:TRX
Watchlist
Price: 0.0725 GBX Market Closed
Market Cap: £5.2m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TRX Price Targets Summary
Tissue Regenix Group PLC

There are no price targets for TRX.
TRX Lowest Forecast
Wall Street Target
Not Available
TRX Average Forecast
Wall Street Target
Not Available
TRX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tissue Regenix Group PLC Competitors:
Price Targets
NYXH
Nyxoah SA
146% Upside
ACAD
ACADIA Pharmaceuticals Inc
42% Upside
TELA
TELA Bio Inc
327% Upside
NYXH
Nyxoah SA
146% Upside
ACAD
ACADIA Pharmaceuticals Inc
42% Upside
TELA
TELA Bio Inc
327% Upside

Revenue
Forecast

53% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
53% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 13 years the compound annual growth rate for Tissue Regenix Group PLC's revenue is 53%. The projected CAGR for the next 2 years is 9%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
137% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
137% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Tissue Regenix Group PLC's operating income for the next 2 years is 137%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
33%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
33%
Average Beat

What are analyst estimates?

See Also

Summary
TRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TRX stock valuation using valuation multiples.
Wall Street Estimates
TRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRX's stock price target?
Not Available

TRX doesn't have any price targets made by Wall Street professionals.

What is Tissue Regenix Group PLC's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Tissue Regenix Group PLC's revenue is 53%. The projected CAGR for the next 2 years is 9%.

What is Tissue Regenix Group PLC's Operating Income forecast?
Projected CAGR
137%

The compound annual growth rate of Tissue Regenix Group PLC's operating income for the next 2 years is 137%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.